July 2009
HealthLeaders Magazine;Jul2009, Vol. 12 Issue 7, p51
The article provides information on the tetherless thermobiochemically actuated microgripper developed at Johns Hopkins University. The device is used for performing biopsylike procedures in hard-to-reach places. The microgripper is made from gold-plated nickel and can be steered by magnets outside of the body. Certain biochemicals or biologically relevant temperatures activate the grippers which extricate cells from the tissue.


Related Articles

  • Product Briefs.  // Medical Device Daily;9/22/2009, Vol. 13 Issue 182, p9 

    The article offers information on products in the U.S. medical device industry including the initiation of a study by Lantheus Medical Imaging on the safety, dosimetry and tolerability of a novel F-18 samll molecule tracer for imaging cardiac neuronal function, Medtronic's process improvement...

  • Development of Laboratory Test Kit for Assessing Plasma Membrane Integrity of Sperm. Misro, Man Mohan // Fertility Weekly;2/11/2008, p6 

    The article presents the study that aims to develop a new hypoosmotic swelling (HOS) test kit for assessing the plasma membrane integrity of human sperm conducted by M.M. Misro and S.P. Chaki of India. The researchers performed a routine semen analysis on 107 samples from couples attending a...

  • INDUSTRY UPDATE.  // MLO: Medical Laboratory Observer;Jul2001, Vol. 33 Issue 7, p52 

    Covers information on laboratory diagnostic equipment and supplies, as of July 2001. Details on the Munchkin R-90M eight-point adjustable ring light from Chiu Technical Corp.; Features of the M120 IR Man Infrared Thermometer from Mikron; Introduction of the ImmunoCard STAT! E. coli 0157 Plus...

  • Do-it-yourself health care boosts sales in home diagnostics category. Heller, Al // Drug Store News;10/6/97, Vol. 19 Issue 16, p21 

    Looks at the growth of the home diagnostics kit category in the United States during the late 1990s. Growing number of products for this category as evidence of this growth; Forecasted growth of this segment; Role of drugstores in the marketing of this product; Examples of hot products under...

  • Cost Saving Tip #18 -- Manage your custom kits. Kaczmarek, David S. // Healthcare Purchasing News;May2005, Vol. 29 Issue 5, p56 

    Presents tips for managing custom kits. Rationale for custom kits; Advantages of using custom kits; Steps that will help manage the use of custom kits.

  • Future looks bright as consumer awareness grows.  // Chain Drug Review;8/17/2009, Vol. 31 Issue 14, p51 

    The article reports on the market performance of the home diagnostic devices in the U.S. According to Bria Monaldo of First Check Diagnostics LLC, the home drug testing segment has grown in 2009 as consumer awareness has continued to build. These at-home test devices range from glucose and...

  • POINT / COUNTER. Ip, Michael S.; Cunha-Vaz, José G. // Ocular Surgery News;5/10/2009, Vol. 27 Issue 9, p11 

    The article presents two opposing views on the importance of spectral domain optical coherence tomography (OCT) findings in comparison to other diagnostic modalities and clinical findings. One writer says that, in general, OCT is a very valuable tool that can help with diagnosis, and in...

  • DiagNano's quantum dots offer more accurate disease detection. YOFFEE, LYNN // Medical Device Daily;10/3/2008, Vol. 12 Issue 211, p1 

    The article offers information on DiagNano, a company launched by Brad Kairdolf by spinning out of the Georgia Tech College of Management and Emory University Law School TI:GER project. A special coating technology was developed by Kairdolf for disease detection. It uses custom quantum dot...

  • Home Pregnancy Testing Kits: Prevalence of Use, False-Negative Rates, and Compliance with Instructions. Valanis, Barbara G.; Perlman, Carol S. // American Journal of Public Health;Sep82, Vol. 72 Issue 9, p1034 

    This study investigated the prevalence of home pregnancy kit use, incidence of false-negative results. and compliance with testing proceduces. Among 144 pregnant women, identified through three health care settings. prevalence of test-kill use was 28.5 per cent. The false-negative rate was 24.3...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics